A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Clinical trial NCT04402060 · COMPLETED

Trial details

NCT number: NCT04402060
Sponsor: Apellis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID Covid-19 Coronavirus Coronavirus Infection Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Coronavirus 2 Sars-CoV2 Ards Acute Respiratory Distress Syndrome

Start date: 2020-05-28
Primary completion: 2021-02-13
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.